EIR Sovereign Pharmaceuticals Nov 2016

Scott Ballard FDA$595.00 - Available Now

FDA investigators audited the Sovereign Pharmaceuticals - Fort Worth, TX, United States facility and issued inspectional observation (via FDA 483) on 10 Nov 2016.

Product details

  • Category:
  • Inspection end: 10 Nov 2016
  • Location: Fort Worth, United States
  • FEI: 3003229412
Add To Cart